Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Puma Biotechnology (PBYI) Accumulated Depreciation & Amortization (2017 - 2025)

Puma Biotechnology's Accumulated Depreciation & Amortization history spans 9 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 41.56% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, down 41.56%, while the annual FY2025 figure was $4.6 million, 41.56% down from the prior year.
  • Accumulated Depreciation & Amortization reached $4.6 million in Q4 2025 per PBYI's latest filing, down from $6.6 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $8.1 million in Q2 2025 to a low of $4.6 million in Q4 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $7.2 million, with a median of $7.5 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 11.54% in 2021, then plummeted 41.56% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $6.9 million in 2021, then rose by 8.23% to $7.4 million in 2022, then increased by 3.42% to $7.7 million in 2023, then increased by 2.45% to $7.9 million in 2024, then plummeted by 41.56% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Accumulated Depreciation & Amortization are $4.6 million (Q4 2025), $6.6 million (Q3 2025), and $8.1 million (Q2 2025).